• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喹唑啉酮类抗惊厥药的结构和分子建模研究。

Structural and molecular modeling studies of quinazolinone anticonvulsants.

作者信息

Duke N E, Codding P W

机构信息

Department of Chemistry, University of Calgary, Alberta, Canada.

出版信息

Acta Crystallogr B. 1993 Aug 1;49 ( Pt 4):719-26. doi: 10.1107/s0108768193000576.

DOI:10.1107/s0108768193000576
PMID:8397980
Abstract

Studies of derivatives of the anticonvulsant methaqualone led to the discovery that unsaturation in the 2-substituent produced active but less toxic compounds; accordingly, 2-arylethanone derivatives have been developed. The crystal structures of five 2-arylethanone derivatives of methaqualone were determined to probe structure-activity relationships. Although these compounds display different activities, the solid-state and calculated structures are similar: each compound is observed as the neamine tautomer containing an intramolecular hydrogen bond between the ethanone and the amine N atom and the molecular conformations are the same. These studies conclude that recognition of the anticonvulsants arises from specific binding of an ortho substituent on the N(3) phenyl substituent, rather than from binding of a particular conformation or tautomeric form adopted by the compound containing an ortho substituent, and that such recognition is characteristic of a broad range of anticonvulsant drugs. Crystal data: [see text].

摘要

对抗惊厥药甲喹酮衍生物的研究导致发现,2-取代基中的不饱和键产生了活性更高但毒性更低的化合物;因此,已开发出2-芳基乙酮衍生物。测定了五种甲喹酮的2-芳基乙酮衍生物的晶体结构,以探究构效关系。尽管这些化合物表现出不同的活性,但固态结构和计算结构相似:每种化合物均以新霉素互变异构体形式存在,在乙酮和胺N原子之间存在分子内氢键,且分子构象相同。这些研究得出结论,抗惊厥药的识别源于N(3)苯基取代基上邻位取代基的特异性结合,而非源于含邻位取代基化合物所采用的特定构象或互变异构形式的结合,并且这种识别是多种抗惊厥药物的特征。晶体数据:[见正文]

相似文献

1
Structural and molecular modeling studies of quinazolinone anticonvulsants.喹唑啉酮类抗惊厥药的结构和分子建模研究。
Acta Crystallogr B. 1993 Aug 1;49 ( Pt 4):719-26. doi: 10.1107/s0108768193000576.
2
Studies on biologically active halogenated compounds. 1. Synthesis and central nervous system depressant activity of 2-(fluoromethyl)-3-aryl-4(3H)-quinazolinone derivatives.生物活性卤代化合物的研究。1. 2-(氟甲基)-3-芳基-4(3H)-喹唑啉酮衍生物的合成及中枢神经系统抑制活性
J Med Chem. 1979 Jan;22(1):95-9. doi: 10.1021/jm00187a021.
3
Molecular modeling and crystallographic studies of 4-amino-N-phenylbenzamide anticonvulsants.4-氨基-N-苯基苯甲酰胺类抗惊厥药的分子建模与晶体学研究。
J Med Chem. 1992 May 15;35(10):1806-12. doi: 10.1021/jm00088a016.
4
Synthesis, Modelling, and Anticonvulsant Studies of New Quinazolines Showing Three Highly Active Compounds with Low Toxicity and High Affinity to the GABA-A Receptor.新型喹唑啉的合成、建模及抗惊厥研究:三种具有低毒性和对GABA-A受体高亲和力的高活性化合物
Molecules. 2017 Jan 24;22(2):188. doi: 10.3390/molecules22020188.
5
Design and synthesis of novel 7-aminoquinazoline derivatives: antitumor and anticonvulsant activities.新型 7-氨基喹唑啉衍生物的设计与合成:抗肿瘤和抗惊厥活性。
Bioorg Med Chem Lett. 2012 Mar 1;22(5):1879-85. doi: 10.1016/j.bmcl.2012.01.071. Epub 2012 Jan 28.
6
1-aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents.1-芳基-6,7-亚甲基二氧基-3H-喹唑啉-4-酮作为抗惊厥剂
Bioorg Med Chem Lett. 2003 Dec 15;13(24):4427-30. doi: 10.1016/j.bmcl.2003.09.032.
7
Design and synthesis of some new quinazolin-4-(3H)-ones as anticonvulsant and antidepressant agents.设计和合成一些新型的喹唑啉-4-(3H)-酮类化合物作为抗惊厥和抗抑郁药物。
Arch Pharm Res. 2013 Jan;36(1):61-8. doi: 10.1007/s12272-013-0004-y.
8
Synthesis and anticonvulsant evaluation of some new 2,3,8-trisubstituted-4(3H)-quinazoline derivatives.一些新型 2,3,8-三取代-4(3H)-喹唑啉衍生物的合成及抗惊厥活性评价。
Bioorg Med Chem Lett. 2012 Jan 1;22(1):327-33. doi: 10.1016/j.bmcl.2011.11.007. Epub 2011 Nov 16.
9
Pharmacological studies on quaternized 4(3H)-quinazolinones.季铵化4(3H)-喹唑啉酮的药理学研究
J Pharm Sci. 1992 Nov;81(11):1092-4. doi: 10.1002/jps.2600811110.
10
Structural Exploration of Quinazolin-4(3H)-ones as Anticonvulsants: Rational Design, Synthesis, Pharmacological Evaluation, and Molecular Docking Studies.喹唑啉-4(3H)-酮类化合物作为抗惊厥剂的结构探索:合理设计、合成、药理学评价及分子对接研究
Arch Pharm (Weinheim). 2016 Nov;349(11):864-880. doi: 10.1002/ardp.201600218. Epub 2016 Sep 28.

引用本文的文献

1
Efficacy of HMJ-38, a new quinazolinone analogue, against the gemcitabine-resistant MIA-PaCa-2 pancreatic cancer cells.新型喹唑啉酮类似物HMJ-38对吉西他滨耐药的MIA-PaCa-2胰腺癌细胞的疗效
Biomedicine (Taipei). 2023 Dec 1;13(4):20-31. doi: 10.37796/2211-8039.1423. eCollection 2023.
2
Crystal structure, Hirshfeld surface analysis and energy framework study of 6-formyl-7,8,9,11-tetra-hydro-5-pyrido[2,1-]quinazolin-11-one.6-甲酰基-7,8,9,11-四氢-5-吡啶并[2,1-]喹唑啉-11-酮的晶体结构、 Hirshfeld表面分析及能量框架研究
Acta Crystallogr E Crystallogr Commun. 2021 Jan 1;77(Pt 1):47-51. doi: 10.1107/S2056989020016059.
3
N-(4-Acetyl-3-methyl-1-phenyl-1H-pyrazol-5-yl)-N-methyl-2-(2-methyl-4-oxo-3,4-dihydroquinazolin-3-yl)benzamide.
N-(4-乙酰基-3-甲基-1-苯基-1H-吡唑-5-基)-N-甲基-2-(2-甲基-4-氧代-3,4-二氢喹唑啉-3-基)苯甲酰胺
Acta Crystallogr Sect E Struct Rep Online. 2013 Sep 25;69(Pt 10):o1582. doi: 10.1107/S1600536813025683. eCollection 2013.